Related Experiment Video
Updated: Dec 3, 2025

08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
5.2K
The use of human biospecimens for research
Roy Aaron1, David Aaron2, Jennifer Racine-Avila1
1Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
Summary
This discussion examines ethical, legal, and financial issues in human biospecimen research regulations. Donor control over biospecimens, consent, and property rights significantly impact research freedom and future models.
Area of Science:
- Bioethics
- Legal Studies
- Biomedical Research Regulation
Background:
- Contemporary research with human biospecimens faces complex ethical, legal, and financial challenges.
- Existing regulatory frameworks grapple with issues of donor autonomy, property rights, and consent for biospecimen donation.
- The concept of donor control over biospecimens, including secondary use, presents potential constraints on research activities.
Purpose of the Study:
- To discuss the ethical, legal, and financial considerations shaping the regulatory landscape for human biospecimen research.
- To analyze the implications of donor autonomy and property rights on consent processes and research freedom.
- To explore the impact of transactional models and donor control on the future of biospecimen research.
Main Methods:
- Review of ethical, legal, and financial issues in human biospecimen research.
- Analysis of consent concepts, including autonomy and property rights.
- Examination of regulatory revisions, judicial opinions, and transactional aspects of biospecimen donation.
Main Results:
- Donor control claims can constrain researcher actions, impacting research freedom.
- The distinction between consent and ownership of biospecimens is crucial.
- Judicial opinions have largely denied property rights for biospecimens, with implications for researchers.
- Treating biospecimens as a commodity introduces constraints and opportunities, with compensation negotiable under contract law.
- Allowing donor control over deidentified biospecimens could inhibit future research.
Conclusions:
- Evolving models of biospecimen donation are emerging due to the complexities of donor control and transactional aspects.
- Balancing donor rights with the needs of the research community is essential for advancing biospecimen research.
- Transparency and autonomy remain key principles in consent regulations, but ownership and control present ongoing challenges.

